Department of Diabetology, Endocrinology, and Nutrition, Bichat-Claude Bernard Hospital, Paris, France
Unité INSERM U1138 Immunity and Metabolism in Diabetes, ImMeDiab Team, Centre de Recherches des Cordeliers, Paris, France.
Diabetes Care. 2021 Jun;44(6):1368-1376. doi: 10.2337/dc20-1690. Epub 2021 Apr 20.
The RELIEF study assessed rates of hospitalization for acute diabetes complications in France before and after initiation of the FreeStyle Libre system.
A total of 74,011 patients with type 1 diabetes or type 2 diabetes who initiated the FreeStyle Libre system were identified from the French national claims database with use of ICD-10 codes, from hospitalizations with diabetes as a contributing diagnosis, or the prescription of insulin. Patients were subclassified based on self-monitoring of blood glucose (SMBG) strip acquisition prior to starting FreeStyle Libre. Hospitalizations for diabetic ketoacidosis (DKA), severe hypoglycemia, diabetes-related coma, and hyperglycemia were recorded for the 12 months before and after initiation.
Hospitalizations for acute diabetes complications fell in type 1 diabetes (-49.0%) and in type 2 diabetes (-39.4%) following FreeStyle Libre initiation. DKA fell in type 1 diabetes (-56.2%) and in type 2 diabetes (-52.1%), as did diabetes-related comas in type 1 diabetes (-39.6%) and in type 2 diabetes (-31.9%). Hospitalizations for hypoglycemia and hyperglycemia decreased in type 2 diabetes (-10.8% and -26.5%, respectively). Before initiation, hospitalizations were most marked for people noncompliant with SMBG and for those with highest acquisition of SMBG, which fell by 54.0% and 51.2%, respectively, following FreeStyle Libre initiation. Persistence with FreeStyle Libre at 12 months was at 98.1%.
This large retrospective study on hospitalizations for acute diabetes complications shows that a significantly lower incidence of admissions for DKA and for diabetes-related coma is associated with use of flash glucose monitoring. This study has significant implications for patient-centered diabetes care and potentially for long-term health economic outcomes.
RELIEF 研究评估了法国在启用 FreeStyle Libre 系统前后急性糖尿病并发症住院率。
从法国国家索赔数据库中使用 ICD-10 代码,根据糖尿病作为合并诊断的住院或胰岛素处方,确定了 74011 名 1 型或 2 型糖尿病患者开始使用 FreeStyle Libre 系统。根据开始使用 FreeStyle Libre 前的自我血糖监测 (SMBG) 条采集情况,对患者进行了亚分类。记录了启用 FreeStyle Libre 前后 12 个月内糖尿病酮症酸中毒 (DKA)、严重低血糖、糖尿病相关昏迷和高血糖的住院情况。
启用 FreeStyle Libre 后,1 型糖尿病 (-49.0%) 和 2 型糖尿病 (-39.4%) 的急性糖尿病并发症住院率下降。1 型糖尿病和 2 型糖尿病的 DKA 分别下降了 (-56.2% 和 -52.1%),1 型糖尿病和 2 型糖尿病的糖尿病相关昏迷分别下降了 (-39.6% 和 -31.9%)。2 型糖尿病的低血糖和高血糖住院率分别下降了 (-10.8% 和 -26.5%)。在开始之前,不符合 SMBG 要求和 SMBG 采集量最高的患者住院情况最为明显,启用 FreeStyle Libre 后,这两种情况分别下降了 54.0% 和 51.2%。12 个月时,FreeStyle Libre 的持续使用率为 98.1%。
这项关于急性糖尿病并发症住院的大型回顾性研究表明,使用即时血糖监测与 DKA 和糖尿病相关昏迷的入院率显著降低相关。这项研究对以患者为中心的糖尿病护理具有重要意义,可能对长期健康经济效益产生影响。